These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32762943)

  • 1. E2F1-induced ferritin heavy chain 1 pseudogene 3 (FTH1P3) accelerates non-small cell lung cancer gefitinib resistance.
    Zheng G; Chen W; Li W; Ding Y; Tu P; Chen W
    Biochem Biophys Res Commun; 2020 Oct; 530(4):624-631. PubMed ID: 32762943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long Noncoding RNA LINC00460 Promotes the Gefitinib Resistance of Nonsmall Cell Lung Cancer Through Epidermal Growth Factor Receptor by Sponging miR-769-5p.
    Ma G; Zhu J; Liu F; Yang Y
    DNA Cell Biol; 2019 Feb; 38(2):176-183. PubMed ID: 30601026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA HOST2 enhances gefitinib-resistance in non-small cell lung cancer by down-regulating miRNA-621.
    Chen ZY; Liu HY; Jiang N; Yuan JM
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9939-9946. PubMed ID: 31799663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
    Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
    Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop.
    Bing Z; Han J; Zheng Z; Liang N
    Life Sci; 2021 Dec; 287():120012. PubMed ID: 34619168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1.
    Chen Z; Chen Q; Cheng Z; Gu J; Feng W; Lei T; Huang J; Pu J; Chen X; Wang Z
    Cell Death Dis; 2020 Oct; 11(10):858. PubMed ID: 33056982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F1-induced long non-coding RNA MCF2L-AS1 modulates Cyclin D1 mRNA stability through ELAVL1 to induce Gefitinib resistance in non-small cell lung cancer.
    Shan KZ; Yang SF; Deng YJ; Yue PY; Du ZQ
    Acta Biochim Pol; 2022 Oct; 69(4):795-804. PubMed ID: 36257058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA FTH1P3 activates paclitaxel resistance in breast cancer through miR-206/ABCB1.
    Wang R; Zhang T; Yang Z; Jiang C; Seng J
    J Cell Mol Med; 2018 Sep; 22(9):4068-4075. PubMed ID: 29971911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of lncRNA FTH1P3 promotes oral squamous cell carcinoma cells migration and invasion by enhancing PI3K/Akt/GSK3b/ Wnt/β-catenin signaling.
    Liu M; Gao X; Liu CL
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8306-8314. PubMed ID: 30556871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA FTH1P3 promotes the proliferation and metastasis of cervical cancer through microRNA‑145.
    Lv R; Zhang QW
    Oncol Rep; 2020 Jan; 43(1):31-40. PubMed ID: 31789421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA prostate cancer-associated transcript 6 inhibited gefitinib sensitivity of non-small cell lung cancer by serving as a competing endogenous RNA of miR-326 to up-regulate interferon-alpha receptor 2.
    Zheng Y; Guo Z; Li Y
    Bioengineered; 2022 Feb; 13(2):3785-3796. PubMed ID: 35081872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of lncRNA FTH1P3 predicts a poor prognosis and promotes aggressive phenotypes of laryngeal squamous cell carcinoma.
    Yuan H; Jiang H; Wang Y; Dong Y
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31142627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of EGFR tyrosine kinase inhibitors resistance associated long noncoding RNA in non-small cell lung cancer.
    Ma P; Zhang M; Nie F; Huang Z; He J; Li W; Han L
    Biomed Pharmacother; 2017 Mar; 87():20-26. PubMed ID: 28040594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC.
    Zhang B; Wang H; Wang Q; Xu J; Jiang P; Li W
    Minerva Med; 2019 Jun; 110(3):273-275. PubMed ID: 30784252
    [No Abstract]   [Full Text] [Related]  

  • 15. The pseudogene DUXAP10 promotes an aggressive phenotype through binding with LSD1 and repressing LATS2 and RRAD in non small cell lung cancer.
    Wei CC; Nie FQ; Jiang LL; Chen QN; Chen ZY; Chen X; Pan X; Liu ZL; Lu BB; Wang ZX
    Oncotarget; 2017 Jan; 8(3):5233-5246. PubMed ID: 28029651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA XIST acts as an oncogene in non-small cell lung cancer by epigenetically repressing KLF2 expression.
    Fang J; Sun CC; Gong C
    Biochem Biophys Res Commun; 2016 Sep; 478(2):811-7. PubMed ID: 27501756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W; Sun M; Zang C; Ma P; He J; Zhang M; Huang Z; Ding Y; Shu Y
    Cell Death Dis; 2016 May; 7(5):e2225. PubMed ID: 27195672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F1-Induced FTH1P3 Promoted Cell Viability and Glycolysis Through miR-377-3p/LDHA Axis in Laryngeal Squamous Cell Carcinoma.
    Zhao L; Zheng Y; Zhang L; Su L
    Cancer Biother Radiopharm; 2022 May; 37(4):276-286. PubMed ID: 33571038
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non-Small Cell Lung Cancer.
    Jang JY; Kim YG; Nam SJ; Keam B; Kim TM; Jeon YK; Kim CW
    Mol Cancer Ther; 2016 Jun; 15(6):1387-96. PubMed ID: 26883272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacin B enhances apoptosis in gefitinib resistant non‑small cell lung cancer by modulating the miR‑17‑5p/STAT3 axis.
    Yu B; Zheng L; Tang H; Wang W; Lin Y
    Mol Med Rep; 2021 Oct; 24(4):. PubMed ID: 34396444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.